Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

939
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
939
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

390
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
390
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

96
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
96
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

53
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
53
Birth Control Methods01:22

Birth Control Methods

5.4K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

43
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effects of hypoxic storage on platelet function and health using a novel storage system.

Transfusion·2024
Same author

Scholarship in anesthesiology: the role of critical appraisal, literature review, quality improvement, journal club, and presentation skills.

International journal of obstetric anesthesia·2023
Same author

"Double-dose desogestrel: Is it effective in adolescent menstrual dysfunction?" - Response to Güven et al.

Journal of pediatric and adolescent gynecology·2022
Same author

Ring and peg electrodes for minimally-Invasive and long-term sub-scalp EEG recordings.

Epilepsy research·2017
Same author

Differential Life History Trait Associations of Aphids with Nonpersistent Viruses in Cucurbits.

Environmental entomology·2015
Same author

Differential expression of candidate salivary effector proteins in field collections of Hessian fly, Mayetiola destructor.

Insect molecular biology·2014

Related Experiment Video

Updated: Nov 5, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

824

Double-Dose Desogestrel: Is it Effective in Adolescent Menstrual Dysfunction?

R C Burton1, C E Williams2

  • 1University of Liverpool, Liverpool, United Kingdom.

Journal of Pediatric and Adolescent Gynecology
|May 14, 2021
PubMed
Summary
This summary is machine-generated.

A double dose of desogestrel effectively manages adolescent menstrual dysfunction (AMD), leading to higher rates of amenorrhea and light spotting. This dosing strategy also showed lower discontinuation rates compared to a single dose.

Keywords:
Abnormal uterine bleedingAdolescenceAmenorrheaDesogestrelMenstrual dysfunctionProgesterone-only pill

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.7K

Related Experiment Videos

Last Updated: Nov 5, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

824
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.7K

Area of Science:

  • Reproductive endocrinology
  • Pediatric gynecology

Background:

  • Adolescent menstrual dysfunction (AMD) is a frequent cause of iron deficiency anemia and school absenteeism.
  • Current management strategies for AMD, particularly with desogestrel, often lack robust evidence, relying heavily on anecdotal data.

Purpose of the Study:

  • To evaluate the effectiveness and safety of single-dose versus double-dose desogestrel regimens for managing adolescent menstrual dysfunction.
  • To provide data-driven insights to guide future clinical management protocols for AMD.

Main Methods:

  • Retrospective analysis of clinic notes from an adolescent gynecology clinic at a tertiary pediatric center.
  • Inclusion of 129 adolescent girls (10-18 years) diagnosed with AMD.
  • Comparison of outcomes between patients receiving single-dose (75 µg) and double-dose (150 µg) desogestrel.

Main Results:

  • A significantly higher prevalence of amenorrhea or light spotting was observed in the double-dose group (49%) compared to the single-dose group (18%) (P = .001).
  • Patients on the double-dose regimen were less likely to discontinue treatment (51%) versus the single-dose group (88%) (P < .001).
  • No significant increase in non-bleeding side effects was noted between the double-dose (34%) and single-dose (38%) groups (P = .68).

Conclusions:

  • The findings suggest that a double dose of desogestrel is more effective in achieving amenorrhea and light spotting for adolescent girls with AMD.
  • The double-dose regimen demonstrated better treatment adherence due to lower discontinuation rates.
  • Further research with larger studies is recommended to solidify these findings and inform clinical guidelines.